• Citer

Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: A multicenter, prospective, pilot trial

par Abramowicz, Daniel ;Vanrenterghem, Yves;Squifflet, Jean-Paul;Kuypers, Dirk;Mourad, Michel;Meurisse, Michel;Wissing, Karl Martin
Référence Clinical transplantation, 19, 4, page (475-482)
Publication Publié, 2005-08

Article révisé par les pairs

• Accès en ligne
• Détails
• Statistiques

Titre:	Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: A multicenter, prospective, pilot trial
Auteur:	Abramowicz, Daniel; Vanrenterghem, Yves; Squifflet, Jean-Paul; Kuypers, Dirk; Mourad, Michel; Meurisse, Michel; Wissing, Karl Martin
Informations sur la publication:	Clinical transplantation, 19, 4, page (475-482)
Statut de publication:	Publié, 2005-08
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Daclizumab
	Mycophenolate mofetil
	Renal transplant
	Steroid-free
	Tacrolimus
Note générale:	SCOPUS: ar.j
	FLWIN
Langue:	Anglais
Identificateurs:	urn:issn:0902-0063
	info:doi/10.1111/j.1399-0012.2005.00369.x
	info:scp/22244490359